ArticleGlycobiology2023
Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors.
Margarita Orozco-Moreno et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it